i-FACTOR Peptide Enhanced Bone Graft in Use at >150 U.S. Hospitals

Cerapedics' i-FACTOR™ Peptide Enhanced Bone Graft is now in use at >150 U.S. hospitals, after market launch in late 1H16.

Last month, the company announced two-year follow-up data from an FDA Investigational Device Exemption trial of i-FACTOR, showing statistic superiority to autograft in overall clinical success in cases of anterior...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us